A Look At Labcorp Holdings (LH) Valuation After Expanded Illumina Precision Oncology Alliance

Simply Wall St.03-20 06:16

Labcorp Holdings (LH) is back in focus after expanding its collaboration with Illumina to broaden access to next generation sequencing based precision oncology tests, spanning both liquid biopsy and ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2620272027?lang=en_US&edition=fundamental","thumbnail":"https://images.simplywall.st/asset/industry/6032000-choice1-main-header/1585186661957","is_english":true,"pubTime":"2026-03-20 06:16","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2620272027","market":"us","top_or_hot":-1,"title":"A Look At Labcorp Holdings (LH) Valuation After Expanded Illumina Precision Oncology Alliance","media":"Simply Wall St.","content":"<div>\n<p>Labcorp Holdings (LH) is back in focus after expanding its collaboration with Illumina to broaden access to next generation sequencing based precision oncology tests, spanning both liquid biopsy and ...</p>\n\n<a href=\"https://simplywall.st/stocks/us/healthcare/nyse-lh/labcorp-holdings/news/a-look-at-labcorp-holdings-lh-valuation-after-expanded-illum\">Source Link</a>\n\n</div>\n","source":"simplywall_highlight","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>A Look At Labcorp Holdings (LH) Valuation After Expanded Illumina Precision Oncology Alliance</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nA Look At Labcorp Holdings (LH) Valuation After Expanded Illumina Precision Oncology Alliance\n</h2>\n\n<h4 class=\"meta\">\n\n\n2026-03-20 06:16 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://simplywall.st/stocks/us/healthcare/nyse-lh/labcorp-holdings/news/a-look-at-labcorp-holdings-lh-valuation-after-expanded-illum><strong>Simply Wall St.</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Labcorp Holdings (LH) is back in focus after expanding its collaboration with Illumina to broaden access to next generation sequencing based precision oncology tests, spanning both liquid biopsy and ...</p>\n\n<a href=\"https://simplywall.st/stocks/us/healthcare/nyse-lh/labcorp-holdings/news/a-look-at-labcorp-holdings-lh-valuation-after-expanded-illum\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"ILMN","symbol_name":"Illumina","start_time":0,"source_url":"https://simplywall.st/stocks/us/healthcare/nyse-lh/labcorp-holdings/news/a-look-at-labcorp-holdings-lh-valuation-after-expanded-illum","article_id":"2620272027","we_media_id":null,"thumbnails":["https://images.simplywall.st/asset/industry/6032000-choice1-main-header/1585186661957"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nyse-lh/labcorp-holdings/news/a-look-at-labcorp-holdings-lh-valuation-after-expanded-illum","rn_cache_url":null,"directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2620272027","pubTimestamp":1773958601,"columns":[],"sourceInfo":{"source_id":"simplywall_highlight","name":"Simply Wall St."},"weMediaInfo":null,"summary":"Labcorp Holdings (LH) is back in focus after expanding its collaboration with Illumina to broaden access to next generation sequencing based precision oncology tests, spanning both liquid biopsy and solid tumor profiling.\nSee our latest analysis for Labcorp Holdings.\nThe Illumina partnership comes as Labcorp’s share price sits at US$264.09, with a 90 day share price return of 4.79% and a 1 year total shareholder return of 13.21%, suggesting momentum that has been building over the medium term...","collect":0,"end_time":0,"defaultTopTitle":"simplywall.st","property":[],"viewcount":null,"language":"en","relate_stocks":{"ILMN":"Illumina","BK4196":"保健护理服务","LU1059921491.USD":"NORDEA 1 GLOBAL STABLE EQUITY \"HB\" (USDHDG) ACC","BK4588":"碎股","BK4550":"红杉资本持仓","BK4585":"ETF&股票定投概念","BK4548":"巴美列捷福持仓","LU0742534661.SGD":"Fidelity America A-SGD (hedged)","BK4534":"瑞士信贷持仓","LU0006061336.USD":"Blackrock US Small and MidCap Opportunities A2 USD","LU2237438978.USD":"Amundi Funds US Pioneer A2 (C) USD","LU0251131958.USD":"FIDELITY AMERICA \"A\" (USD) ACC","BK4535":"淡马锡持仓","LU0048573561.USD":"FIDELITY AMERICA \"A\" (USD) INC","BK4121":"生命科学工具和服务","LH":"徕博科","LU0251142724.SGD":"Fidelity America A-SGD"},"translate_title":"Illumina精准肿瘤联盟扩大后Labcorp Holdings(LH)估值一览","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"LH":1.5,"ILMN":1.5},"content_text":"Labcorp Holdings (LH) is back in focus after expanding its collaboration with Illumina to broaden access to next generation sequencing based precision oncology tests, spanning both liquid biopsy and solid tumor profiling. See our latest analysis for Labcorp Holdings. The Illumina partnership comes as Labcorp’s share price sits at US$264.09, with a 90 day share price return of 4.79% and a 1 year total shareholder return of 13.21%, suggesting momentum that has been building over the medium term rather than fading. If this precision oncology news has your attention, it could be a good moment to broaden your watchlist and check out 35 healthcare AI stocks With Labcorp trading at US$264.09, sitting on a 1 year total shareholder return of 13.21% and flagged with an intrinsic discount of about 32%, investors may ask whether this represents a genuine opportunity or if the market is already pricing in future growth. AdvertisementMost Popular Narrative: 14.2% Undervalued With Labcorp last closing at $264.09 against a narrative fair value of $307.71, the current setup centers on how future earnings and margins might support that gap.  The introduction of new tests in oncology, women's health, autoimmune disease, and neurology is anticipated to capture more test volume and outpace growth in the broader market, positively impacting revenue and earnings. The use of AI and technology innovations is enhancing operational efficiencies, improving margins through platforms like eClaim Assist and Labcorp Diagnostic Assistant.  Read the complete narrative. Curious what has to happen for that valuation to make sense? The narrative focuses on steadier revenue gains, rising profitability, and a future earnings multiple that assumes investors stay confident. Result: Fair Value of $307.71 (UNDERVALUED) Have a read of the narrative in full and understand what's behind the forecasts. However, tariffs, regulatory changes such as PAMA, and sharper competition in diagnostics could pressure margins and keep that valuation gap from closing as expected. Find out about the key risks to this Labcorp Holdings narrative. Next Steps With both concerns and optimism in the mix, does the current setup fit how you see Labcorp’s risk reward trade off, or not yet? To stress test your own view against the data, take a close look at the 3 key rewards and 2 important warning signs Looking for more investment ideas? If Labcorp is on your radar, do not stop there. Broaden your opportunity set by scanning other stocks that fit clear, disciplined criteria using the Simply Wall St screener.  Target resilient balance sheets and steady fundamentals with the solid balance sheet and fundamentals stocks screener (40 results). Hunt for potential value setups other investors might be overlooking through the 48 high quality undervalued stocks. Spot businesses that fly under the radar yet show strong fundamentals using the screener containing 26 high quality undiscovered gems.   This article by Simply Wall St is general in nature. We provide commentary based on historical data\n    and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your\n    financial situation. We aim to bring you long-term focused analysis driven by fundamental data.\n    Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.\n    Simply Wall St has no position in any stocks mentioned.New: AI Stock Screener & AlertsOur new AI Stock Screener scans the market every day to uncover opportunities.• Dividend Powerhouses (3%+ Yield)• Undervalued Small Caps with Insider Buying• High growth Tech and AI CompaniesOr build your own from over 50 metrics.Explore Now for FreeHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"corporation","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.37.0","shortVersion":"4.37.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2620272027","isCrawlerRequest":true}